tykhr
sign in
free sign up
PHAXIAM Therapeutics S.A.
Biotechnology
Healthcare
PHXM
31.02 M shares
NASDAQ US
traded
29 Dec 2023
listed
no
open
4.60
52 week high
13.80
high
4.90
52 week low
3.30
low
4.06
growth
13.27 %
previous Close
4.68
P/E ratio
market cap
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top